Patrick M. Forde

ScholarGPS® ID: 35377012407407

Affiliation

Johns Hopkins University, Baltimore, United States

Affiliation History

Field

Medicine

Discipline

Oncology

Top Specialties

Metrics Summary

Publication Count

196

Predicted Citations

7,765

Predicted h-index

Ranking

Publications and Citation History

Publications based on Top Specialties

Types of Publication

Publications
Books
Patents
NIH/NSF

Add Delete
The Emerging Role of Immunotherapy in Resectable Non-Small Cell Lung Cancer (journal article) Dunne, Elizabeth G. \| Fick, Cameron N. \| Isbell, James M. \| Chaft, Jamie E. \| Altorki, Nasser \| Park, Bernard J. \| Spicer, Jonathan \| Forde, Patrick M. \| Gomez, Daniel \| Iyengar, Puneeth \| ... \| Jones, David R. The Annals of Thoracic Surgery, volume 118, issue 1, pages 119-129 (2024). 10.1016/j.athoracsur.2024.01.024 Cited by (3) \| Cite \| Source
Multi-institution real world analysis of patients with non-small cell lung cancer (NSCLC) treated with standard of care (SOC) neoadjuvant chemo-immunotherapy (chemoIO). (journal article) Cooper, Alissa Jamie \| Gorria, Teresa \| Conroy, Michael R \| Ricciuti, Biagio \| Pecci, Federica \| Aldea, Mihaela \| Anagnostou, Valsamo \| Shaverdian, Narek \| Bott, Matthew \| Forde, Patrick M. \| ... \| Chaft, Jamie E. Journal of Clinical Oncology, volume 42, issue 16_suppl, pages 8049-8049 (2024). 10.1200/JCO.2024.42.16_suppl.8049 Cite \| Source
First-line Osimertinib for Lung Cancer With Uncommon EGFR Exon 19 Mutations and EGFR Compound Mutations (journal article) Cheunkarndee, Tia \| Guo, Matthew Z. \| Houseknecht, Stefanie \| Feliciano, Josephine L. \| Hann, Christine L. \| Lam, Vincent K. \| Levy, Benjamin P. \| Murray, Joseph C. \| Brahmer, Julie R. \| Forde, Patrick M. \| ... \| Scott, Susan C. JTO Clinical and Research Reports, volume 5, issue 6, pages 100686- (2024). 10.1016/j.jtocrr.2024.100686 Cite \| Source
Neoadjuvant Chemoimmunotherapy for NSCLC (journal article) Sorin, Mark \| Prosty, Connor \| Ghaleb, Louis \| Nie, Kathy \| Katergi, Khaled \| Shahzad, Muhammad H. \| Dubé, Laurie-Rose \| Atallah, Aline \| Swaby, Anikka \| Dankner, Matthew \| ... \| Spicer, Jonathan D. JAMA Oncology, volume 10, issue 5, pages 621- (2024). 10.1001/jamaoncol.2024.0057 Cited by (12) \| Cite \| Source
Unmet Needs, Quality of Life, and Financial Toxicity Among Survivors of Lung Cancer (journal article) Hsu, Melinda L. \| Boulanger, Mary C. \| Olson, Sarah \| Eaton, Cyd \| Prichett, Laura \| Guo, Matthew \| Miller, Mattea \| Brahmer, Julie \| Forde, Patrick M. \| Marrone, Kristen A. \| ... \| Feliciano, Josephine L. JAMA Network Open, volume 7, issue 4, pages e246872- (2024). 10.1001/jamanetworkopen.2024.6872 Cite \| Source
Clinical and Genomic Characterization of Long-Term Responders Receiving Immune Checkpoint Blockade for Metastatic Non–Small-Cell Lung Cancer (journal article) Ghanem, Paola \| Murray, Joseph C. \| Hsu, Melinda \| Guo, Matthew Z. \| Ettinger, David S. \| Feliciano, Josephine \| Forde, Patrick \| Hann, Christine L. \| Lam, Vincent K. \| Levy, Benjamin \| ... \| Marrone, Kristen A. Clinical Lung Cancer, volume 25, issue 2, pages 109-118 (2024). 10.1016/j.cllc.2023.11.012 Cite \| Source
90P Real-world (RW) post-progression outcomes and treatment (tx) patterns after first-line (1L) immuno-oncology (IO) regimens in patients (pts) with metastatic (m) NSCLC: CORRELATE (journal article) Liu, S.V. \| Salomonsen, R.J.-B. \| Forde, P.M. \| Naidoo, J. \| Cho, B.C. \| Graziano, V. \| Wang, A. \| Cooper, M. \| Shcherbakova, T. \| Peters, S. ESMO Open, volume 9 (2024). 10.1016/j.esmoop.2024.102669 Cite \| Source
Evaluation of Major Pathologic Response and Pathologic Complete Response as Surrogate End Points for Survival in Randomized Controlled Trials of Neoadjuvant Immune Checkpoint Blockade in Resectable in NSCLC (journal article) Hines, Jacobi B. \| Cameron, Robert B. \| Esposito, Alessandra \| Kim, Leeseul \| Porcu, Luca \| Nuccio, Antonio \| Viscardi, Giuseppe \| Ferrara, Roberto \| Veronesi, Giulia \| Forde, Patrick M. \| ... \| Torri, Valter Journal of Thoracic Oncology (2024). 10.1016/j.jtho.2024.03.010 Cited by (7) \| Cite \| Source
Clinical features and outcomes of advanced HER2+ esophageal/GEJ cancer with brain metastasis (journal article) Liang, K. \| Feliciano, J.L. \| Marrone, K.A. \| Murray, J.C. \| Hann, C.L. \| Anagnostou, V. \| Tackett, S.A. \| Shin, E.J. \| Hales, R.K. \| Voong, K.R. \| ... \| Lam, V.K. ESMO Open, volume 9, issue 1, pages 102199- (2024). 10.1016/j.esmoop.2023.102199 Cite \| Source
A Brief Report on the Patterns of Mediastinal Nodal Failure in Resectable Stage IB-IIIA NSCLC Treated With Neoadjuvant Immunotherapy Combinations, a Secondary Analysis of a Prospective Trial (journal article) Mao, Serena \| Rosner, Samuel \| Forde, Patrick M \| Chaft, Jamie E \| Jones, David R \| Spicer, Jonathan \| Hales, Russell Kenneth \| Ha, Jinny Suk \| Hu, Chen \| Voong, Khinh Ranh Clinical Lung Cancer, volume 25, issue 1, pages e67-e71 (2024). 10.1016/j.cllc.2023.10.008 Cite \| Source
633 A Phase 1a/1b, dose-escalation/dose-expansion study of NPX267 in subjects with solid tumors known to express HHLA2 (conference) Naing, Aung \| Rivera, Ismael Rodriguez \| Johnson, Melissa \| Gainor, Justin \| Ji, Yuan \| Forde, Patrick \| Cheng, Haiying \| Gandhi, Leena \| McDermott, David F SITC 38th Annual Meeting (SITC 2023) Abstracts (2023) 10.1136/jitc-2023-SITC2023.0633 Cite \| Source
597 Preliminary results from LuCa-MERIT-1, a first-in-human Phase I trial evaluating the fixed antigen RNA vaccine BNT116 in patients with advanced non-small cell lung cancer (conference) Deme, Dániel \| Öven, Bala \| Göker, Erdem \| Lang, Istvan \| Brück, Patrick \| Wenger, Michael \| Munshi, Neru \| Schell, Thomas \| Ünsal-Kaçmaz, Kezi \| Markman, Janet \| ... \| Forde, Patrick SITC 38th Annual Meeting (SITC 2023) Abstracts (2023) 10.1136/jitc-2023-SITC2023.0597 Cite \| Source
EP10.01-03 A Phase 1/2 Study of REGN5093-M114, a METxMET Antibody-Drug Conjugate, in Patients with MET-Overexpressing NSCLC (journal article) Drilon, A. \| Awad, M.M. \| Camidge, D.R. \| Forde, P.M. \| Alexander, M. \| Gadgeel, S.M. \| Villaruz, L.C. \| Perez, J. \| Navas, T. \| Daly, C. \| ... \| Rietschel, P. Journal of Thoracic Oncology, volume 18, issue 11, pages S602-S603 (2023). 10.1016/j.jtho.2023.09.1136 Cite \| Source
P1.25-02 Complete Pathologic Response (pCR) as a Surrogate Endpoint in Neoadjuvant Immunotherapy Clinical Trials for NSCLC: A Meta-analysis (journal article) Hines, J. \| Cameron, R. \| Torri, V. \| Cascone, T. \| Forde, P.M. \| Esposito, A. \| Vokes, E. \| Bestvina, C. \| Marina, G.C. \| Porcu, L. Journal of Thoracic Oncology, volume 18, issue 11, pages S268- (2023). 10.1016/j.jtho.2023.09.456 Cite \| Source
Neoadjuvant Immunotherapy for Non-Small Cell Lung Cancer (journal article) Sanber, Khaled \| Rosner, Samuel \| Forde, Patrick M. \| Marrone, Kristen A. BioDrugs, volume 37, issue 6, pages 775-791 (2023). 10.1007/s40259-023-00614-5 Cited by (2) \| Cite \| Source
Improved lung cancer clinical outcomes in patients with autoimmune rheumatic diseases (journal article) Ghanem, Paola \| Murray, Joseph C \| Marrone, Kristen A \| Scott, Susan C \| Feliciano, Josephine L \| Lam, Vincent K \| Hann, Christine L \| Ettinger, David S \| Levy, Benjamin P \| Forde, Patrick M \| ... \| Cappelli, Laura C RMD Open, volume 9, issue 4, pages e003471- (2023). 10.1136/rmdopen-2023-003471 Cite \| Source
Immune-checkpoint inhibition for resectable non-small-cell lung cancer — opportunities and challenges (journal article) Mountzios, Giannis \| Remon, Jordi \| Hendriks, Lizza E. L. \| García-Campelo, Rosario \| Rolfo, Christian \| Van Schil, Paul \| Forde, Patrick M. \| Besse, Benjamin \| Subbiah, Vivek \| Reck, Martin \| ... \| Peters, Solange Nature Reviews Clinical Oncology, volume 20, issue 10, pages 664-677 (2023). 10.1038/s41571-023-00794-7 Cited by (36) \| Cite \| Source
Ablative radiation alone in stage I lung cancer produces an adaptive systemic immune response: insights from a prospective study (journal article) Voong, Khinh Ranh \| Illei, Peter B \| Presson, Bradley \| Singh, Dipika \| Zeng, Zhen \| Lanis, Mara \| Hales, Russell K \| Hu, Chen \| Tran, Phuoc T \| Georgiades, Christos \| ... \| Smith, Kellie N Journal for ImmunoTherapy of Cancer, volume 11, issue 10, pages e007188- (2023). 10.1136/jitc-2023-007188 Cited by (1) \| Cite \| Source
Non-invasive PD-L1 quantification using [18 F]DK222-PET imaging in cancer immunotherapy (journal article) Mishra, Akhilesh \| Gupta, Kuldeep \| Kumar, Dhiraj \| Lofland, Gabriela \| Sharma, Ajay Kumar \| Solnes, Lilja B \| Rowe, Steven P \| Forde, Patrick M \| Pomper, Martin G \| Gabrielson, Edward W \| Nimmagadda, Sridhar Journal for ImmunoTherapy of Cancer, volume 11, issue 10, pages e007535- (2023). 10.1136/jitc-2023-007535 Cited by (6) \| Cite \| Source
Neoadjuvant immune checkpoint blockade: A window of opportunity to advance cancer immunotherapy (journal article) Topalian, Suzanne L. \| Forde, Patrick M. \| Emens, Leisha A. \| Yarchoan, Mark \| Smith, Kellie N. \| Pardoll, Drew M. Cancer Cell, volume 41, issue 9, pages 1551-1566 (2023). 10.1016/j.ccell.2023.07.011 Cited by (48) \| Cite \| Source